Patients in the non-antiviral group, no matter with or without early-stage HCC, had a significantly lower proportion of HBV DNA-negative patients and cirrhotic patients but higher median levels of serum ALT and AST and lower median albumin levels compared to the antiviral group. Here, ALB is linked to hepatocellular carcinoma.